OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
OrbusNeich Medical Group Holdings Ltd
Total Current Assets
OrbusNeich Medical Group Holdings Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
|
Total Current Assets
$361.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
H
|
Huakang Biomedical Holdings Co Ltd
HKEX:8622
|
Total Current Assets
¥57.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
K
|
Kaisa Health Group Holdings Ltd
HKEX:876
|
Total Current Assets
HK$257.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
K
|
Kelfred Holdings Ltd
HKEX:1134
|
Total Current Assets
HK$247.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Arts Optical International Holdings Ltd
HKEX:1120
|
Total Current Assets
HK$872.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
1%
|
|
OrbusNeich Medical Group Holdings Ltd
Glance View
OrbusNeich Medical Group Holdings Ltd. operates as an investment holding company. The company employs 880 full-time employees The company went IPO on 2022-12-23. The firm is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The firm's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The firm mainly conducts its businesses in domestic and overseas markets.
See Also
What is OrbusNeich Medical Group Holdings Ltd's Total Current Assets?
Total Current Assets
361.5m
USD
Based on the financial report for Dec 31, 2025, OrbusNeich Medical Group Holdings Ltd's Total Current Assets amounts to 361.5m USD.
What is OrbusNeich Medical Group Holdings Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
37%
Over the last year, the Total Current Assets growth was 0%. The average annual Total Current Assets growth rates for OrbusNeich Medical Group Holdings Ltd have been 5% over the past three years , 37% over the past five years .
